Teva Fails To Uncover Plans For Generic Copaxone
By Allison Grande ( October 12, 2010, 6:58 PM EDT) -- Teva Pharmaceuticals USA Inc. has lost its bid to force Sandoz Inc. and Momenta Pharmaceuticals Inc. to provide advance notice of their intent and ability to launch a generic version of Teva's multiple sclerosis drug Copaxone....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.